Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Genital herpes

Essential points for quick revision.

Saved on this device
!
Herpes with bladder, neurological, systemic or neonatal danger

Urinary retention, sacral sensory change, meningism, encephalopathy, widespread disease, severe immune compromise or illness in an exposed neonate moves care beyond routine outpatient genital herpes.

Action: Stabilise the patient, assess bladder and neurological function, support analgesia and urine drainage when required, and involve the relevant acute, infection, maternity or paediatric team. Within the adult BASHH genital-herpes population, intravenous aciclovir is used when oral treatment cannot be swallowed or tolerated; CNS, disseminated, pregnancy-associated and neonatal syndromes each require their own current specialist protocol rather than one shared dose.

Synopsis

Recognise genital HSV across first and recurrent episodes, test lesions at the useful moment, treat symptoms promptly, and give practical counselling about recurrence, transmission, relationships and pregnancy.

  • Think of genital HSV when pain, dysuria and tender nodes accompany grouped vesicles or shallow erosions; first episodes may also produce fever and substantial malaise.
  • A recurrence is usually shorter and more localised, and a patient may recognise tingling or burning before lesions return in the same region.
  • Take material from a fresh vesicle or ulcer base for typed HSV NAAT; an HSV blood-antibody result cannot assign the cause of today’s ulcer.

Key red flags

A painful episode accompanied by a palpable bladder or inability to void needs urgent assessment for retention, not advice about dysuria alone.

Perineal numbness, constipation, leg symptoms, severe headache, photophobia, neck stiffness or altered behaviour raises concern for sacral or central nervous-system involvement.

Widespread vesicles, marked constitutional illness, hepatitis, respiratory compromise or shock is an emergency, particularly during pregnancy or major immunosuppression.

Vesicles, conjunctival disease, poor feeding, temperature instability, lethargy or seizures in a neonate with possible exposure requires immediate neonatal assessment and intravenous antiviral treatment.

Suspected first acquisition late in pregnancy needs same-day maternity and sexual-health input because the timing of acquisition drives neonatal risk.

An ulcer that enlarges, becomes hypertrophic or fails to heal despite adherent therapy in advanced HIV requires resampling, resistance work-up and reconsideration of the diagnosis.

Sacral radiculitis

A distended bladder, inability to pass urine, constipation, saddle sensory change or leg symptoms during an episode indicates possible sacral nerve-root dysfunction and requires urgent hospital assessment.

Organ-threatening or extensive infection

Diffuse lesions with encephalopathy, meningism, hepatitis, pneumonitis or sepsis signals disease outside an uncomplicated genital episode and requires syndrome-specific inpatient care.

Pregnancy or neonatal presentation

Possible new maternal infection near birth, active lesions in labour, or illness in an exposed neonate requires immediate maternity or neonatal coordination because management depends on acquisition timing and the infant’s clinical state.

Investigation priorities

01
Typed HSV NAAT from a lesionFirst step

Demonstrate HSV in the symptomatic site and distinguish HSV-1 from HSV-2 for prognosis and counselling.

Management branches

FIRSTTreat the first episode promptly

A compatible first clinical episode began within five days, or fresh lesions are continuing to appear.

  1. Sample an active lesion for typed HSV NAAT and offer syphilis, HIV and site-specific STI testing without making treatment conditional on the results.
  2. Start aciclovir 400 mg orally three times daily for five days.

Key medicines

Aciclovir for first episodeGive 400 mg orally three times daily for five days, starting within five days of onset or while new lesions continue to appear.Review renal function when clinically relevant, maintain hydration and reassess at day five so continuing lesions or poor healing are not overlooked.
Aciclovir episodic recurrenceGive 800 mg orally three times daily for two days, begun during prodrome or immediately when recurrent lesions appear.Provide advance supply only with a clear self-start plan; renal impairment needs dose review and a changed or persistent ulcer needs examination.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 13 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom